IP Library Granted Patent US 12685798
Granted Patent B2
US 12685798 · App. 17/428,256 · Granted Jul 21, 2026

Wound contact layer and dressing for iodine delivery

Inventors: Anthony Dagger (York, GB); Victoria Jody Hammond (Hull, GB); Amy Nicole Wheldrake (Bristol, GB)
Assignee: T.J.Smith and Nephew, Limited
A61L15/26A61L15/30A61L15/44A61L15/60C08L71/02C08L83/04A61L2300/106A61L2300/404
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12685798
App. No.
17/428,256
Granted
Jul 21, 2026
Kind
B2
Abstract

Disclosed embodiments relate to a wound contact layer in the form of a perforated film, possessing one or more of the following functions: speed of kill, sustained kill, broad-spectrum kill against microorganisms, one-piece removal, conformability with a wound surface, compatibility with negative pressure wound treatment, exudate management, autolytic debridement, and self-indicating of changes. The wound contact layer comprises a biocompatible polymeric matrix and, embedded in the matrix, fluid-absorbent particles loaded with therapeutics. The matrix comprises a mixture of an elastomeric composition and a hydrophilic polymer. The film is perforated with an array of holes. A desired loading of therapeutics in the wound contact layer may be tuned by varying the amount of therapeutics loaded within the fluid-absorbent particles, the density of the fluid-absorbent particles within the wound contact layer, the perforation size, and the thickness of the wound contact layer.

Claims (28)

1 . A therapeutic composition, comprising:

a single layer matrix, the matrix comprising:

an elastomeric composition comprising a room temperature vulcanizing silicone; and

a hydrophilic polymer;

a plurality of fluid-absorbent particles embedded in the matrix, individual fluid-absorbent particles configured to swell upon contact with fluid and comprising a crosslinked polymer loaded with an iodine-based antimicrobial agent-powder;

wherein the hydrophilic polymer is configured to form a hydrophilic phase in the matrix, the hydrophilic phase configured to provide a pathway for fluid to travel to the fluid-absorbent particles.

2 . The therapeutic composition of claim 1 , wherein the elastomeric composition comprises between about 10% and about 90% by weight of the composition.

3 . The therapeutic composition of claim 1 , wherein the elastomeric composition comprises one or more silicones.

4 . The therapeutic composition of claim 1 , wherein the elastomeric composition comprises an addition curing room temperature vulcanizing (RTV) silicone made from a mixture of at least one elastomeric composition base and at least one curing agent.

5 . The therapeutic composition of claim 1 , wherein the hydrophilic polymer comprises a polyethylene glycol (PEG).

6 . The therapeutic composition of claim 1 , wherein the PEG comprises an average molecular weight in the range from about 200 to about 1,000 g/mole.

7 . The therapeutic composition of claim 5 , wherein the PEG comprises 20% or less by weight of the composition.

8 . The therapeutic composition of claim 1 , wherein the crosslinked polymer comprises a crosslinked polysaccharide.

9 . The therapeutic composition of claim 1 , wherein the fluid-absorbent particles comprise spherical beads.

10 . The therapeutic composition of claim 1 , wherein the fluid-absorbent particles comprise a diameter of less than 1 mm.

11 . The therapeutic composition of claim 1 , wherein the fluid-absorbent particles comprise between about 30% and about 90% by weight of the composition.

12 . The therapeutic composition of claim 1 , wherein the fluid-absorbent particles comprise preferably between about 50% and about 63% by volume of the composition.

13 . The therapeutic composition of claim 1 , wherein the fluid-absorbent particles comprise cadexomer iodine.

14 . The therapeutic composition of claim 1 , wherein the iodine-based antimicrobial agent comprises less than 2% by weight of the fluid-absorbent particles.

15 . A wound contact layer made from the therapeutic composition of claim 1 .

16 . A wound dressing comprising a layer made from the therapeutic composition of claim 1 .

17 . A multi-care wound contact layer, comprising: a flexible, biocompatible layer having an upper surface and a lower surface defining a thickness there between and an array of holes extending at least partially through the thickness, wherein the flexible, biocompatible layer comprises openings, individual openings adjacent to a plurality of individual internal walls, the layer comprising a single layer matrix, the matrix comprising: a room temperature vulcanizing silicone elastomeric composition and a hydrophilic polymer, wherein the hydrophilic polymer is configured to form a hydrophilic phase in the matrix, the hydrophilic phase configured to provide a pathway for fluid to travel to the fluid-absorbent particles; and a plurality of fluid-absorbent particles embedded in the matrix that are configured to swell upon contact with fluid, individual fluid-absorbent particles comprising a crosslinked polymer loaded with an iodine-based antimicrobial agent powder.

18 . The multi-care wound contact layer of claim 17 , wherein the hydrophilic polymer comprises polyethylene glycol (PEG).

19 . The multi-care wound contact layer of claim 17 , wherein the flexible, biocompatible layer comprises, by weight:

10-90% elastomeric composition;

1-20% hydrophilic polymer; and

30-90% fluid-absorbent particles.

20 . The multi-care wound contact layer of claim 17 , wherein the iodine-based antimicrobial agent comprises less than 2% by weight of the fluid-absorbent particles.